Evidence map›Paper›PMID 27192987›Full record

ArticleInflammation2016

Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response.

Holger Steinbrenner, Esra Bilgic, Antonio Pinto, Melanie Engels, Lena Wollschläger, Laura Döhrn, Kristine Kellermann, Udo Boeken, Payam Akhyari, Artur Lichtenberg

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. The Impact of Selenium Deficiency on Cardiovascular Function.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021
    Review
  13. Article
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Holger SteinbrennerInstitute of Biochemistry and Molecular Biology I, Heinrich-Heine-University, Düsseldorf, Germany.
Esra BilgicDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Antonio PintoDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Melanie EngelsInstitute of Biochemistry and Molecular Biology I, Heinrich-Heine-University, Düsseldorf, Germany.
Lena WollschlägerInstitute of Biochemistry and Molecular Biology I, Heinrich-Heine-University, Düsseldorf, Germany.
Laura DöhrnDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Kristine KellermannClinic for Anaesthesiology, Klinikum rechts der Isar, Technische Universität, Munich, Germany.
Udo BoekenDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany. udo.boeken@med.uni-duesseldorf.de.
Payam AkhyariDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Artur LichtenbergDepartment of Cardiovascular Surgery, University Hospital, Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Düsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DEKlinikum rechts der Isar · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia/reperfusion injury (IRI) contributes to morbidity and mortality after cardiovascular surgery requiring cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA). Multi-organ damage is associated with substantial decreases of blood selenium (Se) levels in patients undergoing cardiac surgery with CPB. We compared the influence of a dietary surplus of Se and pretreatment with ebselen, a mimic of the selenoenzyme glutathione peroxidase, on IRI-induced tissue damage and inflammation. Male Wistar rats were fed either a Se-adequate diet containing 0.3 ppm Se or supplemented with 1 ppm Se (as sodium selenite) for 5 weeks. Two other groups of Se-adequate rats received intraperitoneal injection of ebselen (30 mg/kg) or DMSO (solvent control) before surgery. The animals were connected to a heart-lung-machine and underwent 45 min of global ischemia during circulatory arrest at 16 °C, followed by re-warming and reperfusion. Selenite and ebselen suppressed IRI-induced leukocytosis and the increase in plasma levels of tissue damage markers (AST, ALT, LDH, troponin) during surgery but did not prevent the induction of proinflammatory cytokines (IL-6, TNF-α). Both Se compounds affected phosphorylation and expression of proteins related to stress response and inflammation: Ebselen increased phosphorylation of STAT3 transcription factor in the heart and decreased phosphorylation of ERK1/2 MAP kinases in the lungs. Selenite decreased ERK1/2 phosphorylation and HSP-70 expression in the heart. Pretreatment with selenite or ebselen protected against acute IRI-induced tissue damage during CPB and DHCA. Potential implications of their different actions with regard to molecular stress markers on the recovery after surgery represent promising targets for further investigation.

Indexed as

AnimalsAzolesCardiopulmonary BypassDietary SupplementsHypothermia, InducedInflammationIsoindolesLeukocytosisMaleOrganoselenium CompoundsOrgans at RiskPhosphorylationPre-Exposure ProphylaxisRatsRats, WistarReperfusion InjuryAzolesebselenIsoindolesOrganoselenium CompoundsSeleniumcardioprotectioncardiopulmonary bypassdeep hypothermic circulatory arrestischemia/reperfusion injuryselenium

Identifiers

PMID27192987
OpenAlexW2405946890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.